A

AMSilk | Biogenius Materials Tech Stack

Engineered silk proteins for textiles, biomedics, and consumer goods

Biotechnology Research Neuried, Bavaria 51–200 employees Founded 2008 Public Company

AMSilk manufactures biopolymers derived from silk proteins using protein engineering and precision fermentation. The company is actively scaling from lab to production while managing quality control across outsourced manufacturing — a classic biotech growing pain. Hiring is accelerating with a research and engineering focus, anchored by recent appointment of a Head of Quality, reflecting the regulatory and manufacturing hurdles ahead of commercialization.

Tech Stack 10 technologies

Core StackPython Microsoft Office Word Outlook Teams Excel PowerPoint SQL JMP Minitab

What AMSilk | Biogenius Materials Is Building

◆Challenges

Replacing unsustainable materials
Scale-up from lab to production
Optimizing organizational processes
Extending quality management system certifications
Quality control at outsourced production
Managing quality deviations root cause
Technology transfer
Securing investment capital
Managing investor relations
Preparing pitch deck

▲Active Projects

Targeted sales strategy for luxury textile market
Commercial representation at trade shows
Protein purification process development
Labor infrastructure development
Internal events planning
Board meeting coordination
Launch of multiple new products
Quality regulatory compliance projects
Fundraising process
Data room management

Hiring Activity

Accelerating9 roles · 5 in 30d

Department

Engineering

3

Research

2

Executive

1

Finance

1

Quality

1

Sales

1

Seniority

Mid

4

Senior

3

Junior

1

Lead

1

Notable leadership hires: Head of Quality

Company intelligence

Find more companies like AMSilk | Biogenius Materials by tech stack, pain points and active projects

Get started free

About AMSilk | Biogenius Materials

AMSilk, founded in 2008 and headquartered in Neuried, Bavaria, engineers silk-protein-based materials for textile, biomedical, homecare, and automotive applications. The company transforms biogenic proteins into fibers, yarns, hydrogels, and powders using DNA editing and precision fermentation. Operations span product development, regulatory compliance, manufacturing scale-up, and sales targeting luxury and industrial segments. The organization is publicly traded and employs 51–200 people.

HeadquartersNeuried, Bavaria

Company Size51–200 employees

Founded2008

Hiring MarketsGermany

Frequently Asked Questions

What is AMSilk's primary technology?

AMSilk manufactures advanced biomaterials made from engineered silk proteins using protein engineering and precision fermentation. Products include fibers, yarns, hydrogels, and silk powder for textile, biomedical, homecare, and automotive markets.